Estrogen Receptor Macrophages Shield Bone Metastases from Immune Attack
A novel cell-labeling tool reveals how ERα+ macrophages create immune-excluded niches in bone, blocking T cells from destroying cancer.
Summary
Researchers developed a new molecular tool called SAMENT to map the cellular neighborhoods surrounding cancer cells as they colonize bone. They discovered that metastatic niches in bone are dominated by macrophages that carry estrogen receptor alpha (ERα), and that these macrophages actively suppress T cell infiltration. When ERα was deleted from macrophages in mouse models, T cells were able to enter the tumor site and bone colonization was significantly reduced. The same ERα-positive macrophages were found in human bone metastasis samples across multiple cancer types. This work identifies a previously unrecognized immune evasion mechanism and suggests that targeting macrophage ERα signaling could be a new strategy to make bone metastases vulnerable to immune attack.
Detailed Summary
Bone metastasis is one of the most common and devastating complications of advanced cancers, particularly breast cancer. Despite progress in immunotherapy, bone metastases remain largely resistant to immune-based treatments. Understanding why immune cells fail to infiltrate these tumors is critical to improving outcomes for patients with metastatic disease.
To investigate the microenvironment surrounding metastatic cancer cells, researchers at Baylor College of Medicine and collaborating institutions developed a new tool called SAMENT — sortase A-based microenvironment niche tagging. This system selectively labels cells that physically interact with cancer cells during metastasis, allowing unbiased mapping of the niche without prior assumptions about which cell types matter.
Applying SAMENT across multiple cancer models and target organs, the team found consistent patterns: metastatic niches are enriched for macrophages and depleted of T cells. In bone specifically, the dominant macrophage population expressed estrogen receptor alpha (ERα) with active downstream signaling. This was not a passive association — conditional deletion of the Esr1 gene in macrophages allowed T cells to infiltrate bone metastases and significantly impaired cancer colonization in mouse models. Critically, ERα-positive macrophages were also identified in human bone metastasis specimens across several cancer types, validating the clinical relevance of the finding.
These results establish macrophage ERα signaling as a key driver of the immune-excluded phenotype in bone metastases. The mechanism appears to involve macrophages actively suppressing T cell entry into the tumor niche, creating a protected sanctuary for cancer cells.
The implications are significant: ERα inhibition in macrophages — potentially through existing anti-estrogen drugs — could sensitize bone metastases to immunotherapy. However, the full mechanistic pathway linking ERα signaling to T cell exclusion remains to be elucidated, and translation to clinical settings will require further study.
Key Findings
- SAMENT tool enables unbiased mapping of cells surrounding metastatic cancer cells in vivo.
- Bone metastatic niches are enriched for ERα+ macrophages with active estrogen receptor signaling.
- Deleting ERα in macrophages allowed T cell infiltration and significantly reduced bone colonization in mice.
- ERα+ macrophages were confirmed in human bone metastases across multiple cancer types.
- Macrophage ERα signaling is identified as a key driver of immune exclusion in bone metastasis.
Methodology
Researchers developed SAMENT, a sortase A-based proximity labeling system, to tag cells in direct contact with metastatic cancer cells across multiple mouse cancer models and organ sites. Conditional macrophage-specific Esr1 knockout mice were used to test the functional role of ERα signaling. Human bone metastasis tissue samples were analyzed to validate findings across cancer types.
Study Limitations
This summary is based on the abstract only, as the full text is not open access; detailed mechanistic data, statistical analyses, and experimental specifics are unavailable. The mouse model findings may not fully recapitulate human bone metastasis biology, and the precise molecular pathway by which ERα in macrophages suppresses T cell infiltration has not yet been fully characterized. Clinical translation will require prospective studies to determine whether ERα inhibition in macrophages is achievable without systemic hormonal side effects.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.